BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1480065)

  • 1. Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption.
    Vaes G; Delaissé JM; Eeckhout Y
    Matrix Suppl; 1992; 1():383-8. PubMed ID: 1480065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of collagenase in bone resorption. An overview.
    Eeckhout Y; Delaisse JM
    Pathol Biol (Paris); 1988 Nov; 36(9):1139-46. PubMed ID: 2851768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.
    Vaes G
    Clin Orthop Relat Res; 1988 Jun; (231):239-71. PubMed ID: 3286076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue.
    Delaisse JM; Eeckhout Y; Vaes G
    Endocrinology; 1988 Jul; 123(1):264-76. PubMed ID: 2838255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.
    Everts V; Delaissé JM; Korper W; Niehof A; Vaes G; Beertsen W
    J Cell Physiol; 1992 Feb; 150(2):221-31. PubMed ID: 1734028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activators are involved in the degradation of bone by osteoclasts.
    Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
    Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat.
    Klapisz-Wolikow M; Saffar JL
    J Cell Physiol; 1996 May; 167(2):359-68. PubMed ID: 8613479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
    Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
    Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.
    Huffer WE
    Lab Invest; 1988 Oct; 59(4):418-42. PubMed ID: 3050272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment.
    Delaissé JM; Eeckhout Y; Neff L; François-Gillet C; Henriet P; Su Y; Vaes G; Baron R
    J Cell Sci; 1993 Dec; 106 ( Pt 4)():1071-82. PubMed ID: 8126092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.
    Parikka V; Väänänen A; Risteli J; Salo T; Sorsa T; Väänänen HK; Lehenkari P
    Matrix Biol; 2005 Sep; 24(6):438-47. PubMed ID: 16098718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different cysteine proteinases involved in bone resorption and osteoclast formation.
    Brage M; Abrahamson M; Lindström V; Grubb A; Lerner UH
    Calcif Tissue Int; 2005 Jun; 76(6):439-47. PubMed ID: 15906014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
    Okada Y; Naka K; Kawamura K; Matsumoto T; Nakanishi I; Fujimoto N; Sato H; Seiki M
    Lab Invest; 1995 Mar; 72(3):311-22. PubMed ID: 7898050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteoclasts in bone metabolism].
    Hakeda Y; Kumegawa M
    Kaibogaku Zasshi; 1991 Aug; 66(4):215-25. PubMed ID: 1759556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
    Shorey S; Heersche JN; Manolson MF
    Bone; 2004 Oct; 35(4):909-17. PubMed ID: 15454098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of collagen fibrils by live cells: role of expression and activation of procollagenase.
    Birkedal-Hansen H; Lin HY; Birkedal-Hansen B; Windsor LJ; Pierson MC
    Matrix Suppl; 1992; 1():368-74. PubMed ID: 1480062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast bone resorption is enhanced in the presence of osteoblasts.
    Grano M; Colucci S; Cantatore FP; Teti A; Zambonin Zallone A
    Boll Soc Ital Biol Sper; 1990 Nov; 66(11):1051-7. PubMed ID: 2095815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and enzymatic basis of bone resorption by human osteoclasts.
    Fuller K; Kirstein B; Chambers TJ
    Clin Sci (Lond); 2007 Jun; 112(11):567-75. PubMed ID: 17241109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bone resorption by selective inactivators of cysteine proteinases.
    Hill PA; Buttle DJ; Jones SJ; Boyde A; Murata M; Reynolds JJ; Meikle MC
    J Cell Biochem; 1994 Sep; 56(1):118-30. PubMed ID: 7806585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.